Ovarian Tissue Current Events | Ovarian Tissue News | 3
|
| Page
3 of
32 |
636 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers identify ovarian cancer biomarkers
Researchers have identified markers unique to the cells of blood vessels running through ovarian tumors. The finding, while preliminary, could one day improve screening, diagnosis and treatment for this disease. view more (2007-03-08)
Researchers identify ovarian cancer biomarkers
Researchers have identified markers unique to the cells of blood vessels running through ovarian tumors. The finding, while preliminary, could one day improve screening, diagnosis and treatment for this disease. view more (2007-03-08)
'Clumping' protein linked to return of ovarian cancer
Johns Hopkins scientists have discovered that women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth and slows down cell death, both hallmarks of malignancy. view more (2006-12-18)
Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by researchers from The University of Texas M. D. Anderson Cancer Center. view more (2008-03-11)
Swedish researchers link endometriosis with increased risk of some cancers
Madrid, Spain: Women with endometriosis have an increased risk of developing ovarian cancer, non-Hodgkin's lymphoma, endocrine and brain cancers, a Swedish researcher told the annual meeting of the European Society of Human Reproduction and Embryology today (Wednesday 2 July). However, Dr Anna-Sofia Berglund said that since these were relatively... view more... (2003-06-29)
Prophylactic surgeries prevent two gynecological cancers in women with Lynch syndrome
Women diagnosed with Lynch syndrome, a condition often associated with colon cancer, also are at high risk for endometrial and ovarian cancers-both of which can be eliminated by having a prophylactic hysterectomy and oophorectomy (removal of the ovaries). view more (2006-01-19)
Minimizing obesity's impact on ovarian cancer survival
Obesity affects health in several ways, but new research shows obesity can have minimal impact on ovarian cancer survival. A study by researchers at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center found ovarian cancer survival rates are the same for obese and non-obese women if their chemotherapy doses are closely matched... view more... (2008-12-29)
Ovarian cancer responds to aspirin derivative with chemo
A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy. view more (2006-02-16)
Study suggests chemotherapy diminishes fertility in breast cancer patients
Pre-menopausal breast cancer survivors who were treated with chemotherapy following surgery were more likely to have diminished ovarian reserve - the capacity of the ovaries to provide eggs capable of being fertilized - compared to women who have never had breast cancer, according to a study led by Dana-Farber Cancer Institute investigators. view more (2008-05-30)
Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
Researchers from The University of Texas M. D. Anderson Cancer Center have found that increased angiogenesis, or blood vessel formation, and vascular endothelial growth factor expression are associated with poor survival in women with sex cord-stromal ovarian tumors. view more (2009-02-06)
Underutilized treatment for advanced ovarian cancer found to significantly improve survival
According to a study published in the January 5 issue of the New England Journal of Medicine, women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median survival time 16 months longer than women who received IV chemotherapy... view more... (2006-01-05)
RNA splicing factor implicated in ovarian tumor cell growth
An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago. view more (2007-04-10)
Study reveals why certain ovarian cancers develop resistance to platinum-based chemotherapy
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature. view more (2008-02-11)
New technique could save cancer patients' fertility
The tiny translucent egg nestled in the special laboratory gel was a mere 30 days old, but its four-week birthday caused researchers to quietly celebrate. view more (2009-07-14)
Computer-Assisted Detection Of Proteomic Pattern Could Help Screening For Ovarian Cancer
Issue 16 February 2002 - Early Web Publication: Friday 8 February 2002 A sensitive and non-invasive computer-assisted technique which assesses proteomic patterns in blood could be a step towards effective screening for ovarian cancer, conclude authors of a fast-track study published on The Lancet website this week.* New technologies for the... view more... (2002-02-06)
Nanoparticle-delivered 'suicide' genes slowed ovarian tumor growth
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research. view more (2009-07-30)
Dormant cancer cells rely on cellular self-cannibalization to survive
A single tumor-suppressing gene is a key to understanding, and perhaps killing, dormant ovarian cancer cells that persist after initial treatment only to reawaken years later, researchers at The University of Texas M. D. Anderson Cancer Center report in the December Journal of Clinical Investigation. view more (2009-01-05)
The role of hormones in ovarian and endometrial cancers
High levels of the growth factor IGF-I can indicate increased risk of ovarian cancer before the age of 55. This is a finding put forward in a dissertation from Annekatrin Lukanova, Ume'å University, Sweden. The main objective of her thesis was to examine the relationship of pre-diagnostic circulating levels of sex-steroids (androgens and... view more... (2004-04-15)
New treatment in sight for ovarian cancer
In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells. view more (2009-08-31)
Ovarian cancer stem cells identified, characterized
Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer's recurrence and its resistance to chemotherapy. view more (2008-04-18)
|
|
| Page
3 of
32 |
636 Results |
|
|
|
Sort By:
Page Views | Date |
|
